Why the study?
To describe renal function in individuals newly diagnosed with non-valvular atrial fibrillation in England and evaluate how oral anticoagulant treatment varies according to renal function.
How does oral anticoagulant treatment initiation vary according to renal function in patients newly diagnosed with non-valvular atrial fibrillation?
How does oral anticoagulant treatment initiation vary according to renal function in patients newly diagnosed with non-valvular atrial fibrillation?
There is a high prevalence of renal dysfunction among incident non-valvular AF patients, and those with severe dysfunction are less likely to be initiated on oral anticoagulants.
No takes yet. Share an insight, caveat, or question.
Renal dysfunction is common at NVAF diagnosis; leaves open optimal OAC initiation by eGFR.
Ramagopalan et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: